Author details

Full Name

Alison W Rebman

Affiliation

ORCID

Career Start Year

2012

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36746657	Initial Presentation and Time to Treatment in Early Lyme Disease.		2023
35667636	Disseminated Lyme disease and dilated cardiomyopathy: A systematic review.	Trends in Cardiovascular Medicine	2023
37644525	Outpatient visits before and after Lyme disease diagnosis in a Maryland employer-based health plan.		2023
38085545	Time to Diagnosis and Treatment of Lyme Disease by Patient Race.		2023
35066160	Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.	International Journal of Infectious Diseases	2022
36288329	A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease.	PLoS ONE	2022
35879995	A diagnostic classifier for gene expression-based identification of early Lyme disease.	Commun Med (Lond)	2022
35734473	Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease.	Front Neurol	2022
36384094	Gene set predictor for post-treatment Lyme disease.	Cell Rep Med	2022
34485323	Recent Progress in Lyme Disease and Remaining Challenges.	Front Med (Lausanne)	2021
33684352	Long-haul COVID: heed the lessons from other infection-triggered illnesses.	Lancet, The	2021
34003960	Contrast Sensitivity Loss in Patients With Posttreatment Lyme Disease.	Transl Vis Sci Technol	2021
33682067	The presenting characteristics of erythema migrans vary by age, sex, duration, and body location.	Infection	2021
33763080	Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing.	Front Immunol	2021
33441353	Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study.	BMJ Open	2021
32975577	Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.	Clinical Infectious Diseases	2021
34851988	The Lyme and Tickborne Disease Dashboard: A map-based resource to promote public health awareness and research collaboration.	PLoS ONE	2021
33324657	Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study.	Front Med (Lausanne)	2020
31618575	Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease.	J Proteome Res	2020
32161761	Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease.	Frontiers in Medicine	2020
32994327	A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.	mBio	2020
33087434	Molecular Microbiological and Immune Characterization of a Cohort of Patients Diagnosed with Early Lyme Disease.	Journal of Clinical Microbiology	2020
32949845	AI-based detection of erythema migrans and disambiguation against other skin lesions.	Computers in Biology and Medicine	2020
31036693	Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.	Antimicrobial Agents and Chemotherapy	2019
32025430	Lyme Disease with Erythema Migrans and Seventh Nerve Palsy in an African-American Man.		2019
31867334	The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease.	Frontiers in Medicine	2019
29945190	Cognitive Decline in Post-treatment Lyme Disease Syndrome.	Archives of Clinical Neuropsychology	2019
30654165	Automated detection of erythema migrans and other confounding skin lesions via deep learning.	Computers in Biology and Medicine	2019
29452400	Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.	Sleep	2018
30072990	Robust B Cell Responses Predict Rapid Resolution of Lyme Disease.	Frontiers in Immunology	2018
29955850	Incidence of Lyme Disease Diagnosis in a Maryland Medicaid Population, 2004-2011.	American Journal of Epidemiology	2018
30567544	Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [C]DPA-713 PET.	Journal of Neuroinflammation	2018
29895655	Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study.	BMJ Open	2018
26631681	Living in Limbo: Contested Narratives of Patients With Chronic Symptoms Following Lyme Disease.	Qualitative Health Research	2017
28365751	Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.	Archives of Clinical Neuropsychology	2017
29312942	The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.	Frontiers in Medicine	2017
27358211	CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.	Clinical and Vaccine Immunology	2016
26873097	Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease.	mBio	2016
24924604	Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients.	Clinical Rheumatology	2015
26447113	Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.	Journal of Clinical Microbiology	2015
22294245	Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?	Quality of Life Research	2013
22590620	Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease.	PLoS ONE	2012
22853630	Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection.	BMC Infectious Diseases	2012